Past Event
16 April 2022 - 20 April 2022,
University of Siena, Italy
Co‑chaired by Emanuele Montomoli (University of Siena, Italy) Jackie Katz (CDC, USA), and John Wood Lars (NIBSC, UK).
35 participants from across the globe—including Australia, Europe, Egypt, Senegal, India, the Philippines, South America, and the USA. Honouring his legacy, seven Lars Haaheim Scholarships were awarded to students from developing countries, as well as generous support from the ISIRV Antiviral Group and the Wellcome Trust.
Five-day intensive with attendees received a comprehensive introduction to influenza, encompassing key concepts, laboratory methods, and real-world applications. There were 7 core themes; History, Epidemiology, and Ecology of Influenza; Prevention and Control; Virology and Pathogenesis; Immunity to Influenza; Influenza Vaccines;
Interactive group discussions, lab demonstrations, student posters and networking.
Faculty Highlights: 25 expert lecturers from leading institutions.
| Theme | Session / Title | Speaker & Affiliation |
| Day 1: 16 July 2012 | ||
| Welcome & Introduction | Emanuele Montomoli (University of Siena), John Wood (NIBSC, UK), Jackie Katz (CDC, USA) | |
| Theme 1: History, Epidemiology & Ecology | Medical and social impact of pandemics from 1918-2009 | John Oxford (Retroscreen) |
| Global influenza epidemiology and surveillance | Lyn Finelli (CDC, USA) | |
| Special Seminar | Vaccination: past, present and future | Rino Rappuoli (Novartis) |
| Special Topic | Lessons learned from the Pandemic 2009 – the ECDC Perspective | Angus Nicoll (ECDC) |
| Theme 1 History, Epidemiology & Ecology (continued) | Animal influenza | Giovanni Cattoli (IZS Venezie, Italy) |
| Student Presentations | Arguelles, Borborema, Broberg, Meseko, Etschmeier, Fragaszy | |
| Day 2: 17 July 2012 | ||
| Theme 2: Prevention and Control | Virological diagnosis and surveillance | Olav Hungnes (Norwegian Institute of Public Health, Norway) |
| Influenza disease burden and vaccination policies | Jon Van Tam (University of Nottingham, UK) | |
| Effectiveness of vaccines and antivirals | John Treanor (University of Rochester Medical Center, USA) | |
| Theme 3: Virology and Pathogenesis | Virus structure and replication | Sylvie Van der Werf (Institut Pasteur, Paris, France) |
| Pathogenesis and host range | Hans Dieter Klenk (University of Marburg, Germany): | |
| Transmissibility and the influence of the host | Wendy Barclay (Imperial College, London, UK) | |
| Day 3: 18 July 2012 | ||
| Theme 4: Immunity to Influenza | Human influenza management | Karl Nicholson (UK) |
| The immune response to influenza infection | Jackie Katz (CDC, USA) | |
| Immune correlates of protection against influenza | Rebecca JCox (University of Bergen, Norway) | |
| Theme 5: Influenza vaccines | Inactivated vaccines | Otfried Kistner (Baxter Innovation GmbH) |
| Live attenuated vaccines | John Treanor (University of Rochester Medical Center, USA) | |
| Plant-based influenza vaccines | Nathalie Landry (Médicago Inc., Québec, Canada | |
| Day 4: 19 July 2012 | ||
| Theme 6: Antivirals & Therapies | Redox-regulated intracellular pathways as new potential targets for anti-influenza drugs | Anna Teresa Palamara (Sapienza University of Rome, Italy) |
| Treating the host response in severe disease | David S. Fedson (Sergy Haut, France | |
| Influenza antivirals | Alan Hay (National Institute for Medical Research, London, UK) | |
| Theme 7: Regulatory Practices and challenges | Regulatory challenges for influenza vaccines
| Leonoor Wijnans ((Medicines Evaluation Board, The Netherlands): |
| Student Presentations | Kumar, Kurz, Moorthy, Newitt, Perini, Sacramento, Tabinov, Vaccari | |
| Day 5: 20 July 2012 | ||
| Theme 7: regulatory practices and challenges (continued) | Licensing & standardisation | John Wood (National Institute for Biological Standards and Control, Hertfordshire, UK – retired) |
| theme 5: influenza vaccines (continued) | New vaccine technologies | Alan Shaw (VaxInnate Corporation, Cranbury, USA) |
| Closing Remarks | ||
